Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Mersana Therapeutics to Present at Upcoming Investor Conferences | ||||||||||
By: GlobeNewswire - 27 Feb 2024 | Back to overview list |
|||||||||
CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that members of management will present at the following upcoming investor conferences: TD Cowen 44th Annual Health Care Conference
About Mersana Therapeutics Contact: |
||||||||||
|
||||||||||
Copyright 2024 GlobeNewswire | Back to overview list |